Oridonin is a type of Active Compound and its properties as follows :-
Dietry_product Qty/100gram Qty/day (Min-Max) T_half (Min-Max) Peak value (Min-Max)       Qty/gm_Ref        Qty/gm_Url            Qty/day_Ref        Qty/day_Url            T_half_Ref        T_half_Url         Peak value_Ref       Peak value_Url     
Blusmined rabdosia 11.42-45 (minute) 105 (minute)
Oridonin is a type of Active Compound and its properties as follows :-
Enhencer Effect Reference Url
Oridonin is a type of Active Compound and its properties as follows :-
Inhibitor Effect Ref Url
Oridonin is a type of Active Compound and its properties as follows :-
Dietry_product Type Temperatute Ref_Temp Url_Temp
Blusmined rabdosia oil 250 ℃ Fujita, T., Takao, S., & Fujita, E. (1979). Biosynthesis of natural products. Part 4. Biosynthesis of enmein and oridonin from mono- or di-oxygenated kaurenoids. Journal of the Chemical Society, Perkin Transactions 1 J. Chem. Soc., Perkin Trans. 1, 2468. http://www.chemspider.com/Chemical-Structure.23326877.html
Blusmined rabdosia oil 250 ℃ Fujita, T., Takao, S., & Fujita, E. (1979). Biosynthesis of natural products. Part 4. Biosynthesis of enmein and oridonin from mono- or di-oxygenated kaurenoids. Journal of the Chemical Society, Perkin Transactions 1 J. Chem. Soc., Perkin Trans. 1, 2468. http://www.chemspider.com/Chemical-Structure.23326877.html

Pathway of Dietry Product


​   ► Medicine for Oridonin as follows :-
'Not Found'

Dietry Substance Interactions


​   ► Oridonin interact with medicines having some effect as follows :-
'Not Found'

ContraIndication Dietry Substance


​   ► Oridonin Contraindicate with medicines as follows :-
'Not Found'